ProfileOfResearchers

TÃTULO: Transthyretin-directed antisense oligonucleotide therapy effects on ATTRv myocardiopathy
AUTORES: Beatriz Garcia, A. Ana; Agostinho, J.; Oliveira, C.; Martins, M.; Brito, J.; Da Silva, P. Alves; Silva, B.; Raposo, M.; Gregorio, C.; Abrantes, A.; Campos, C.; Santos, M.; Conceicao, I.; Pinto, F. ; Brito, D. ;
PUBLICAÇÃO: 2023, FONTE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 25

INDEXADO EM:

WOS

TÃTULO: A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS)
AUTORES: Coelho, Teresa; Conceicao, Isabel; Waddington Cruz, Marcia; Keohane, Denis; Sultan, Marla B.; Chapman, Doug; Amass, Leslie;
PUBLICAÇÃO: 2022, FONTE: AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

INDEXADO EM:

Scopus

WOS

TÃTULO: Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients? Full Text
AUTORES: Conceicao, Isabel; de Castro, Isabel; Diaz, Andres; Castro, Jose;
PUBLICAÇÃO: 2022, FONTE: AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

INDEXADO EM:

WOS

TÃTULO: Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale Full Text
AUTORES: Singer, S; Hammerlid, E; Tomaszewska, IM; Amdal, CD; Bjordal, K; Herlofson, BB; Santos, M; Silva, JC; Mehanna, H; Fullerton, A; Brannan, C; Gonzalez, LF; Inhestern, J; Pinto, M; Arraras, JI; Yarom, N; Bonomo, P; Baumann, I; Galalae, R; Nicolatou Galitis, O; Kiyota, N; Raber Durlacher, J; Salem, D; Fabian, A; Boehm, A; Krejovic Trivic, S; Chie, WC; Taylor, K; Simon, C; Licitra, L; Sherman, AC; ...Mais
PUBLICAÇÃO: 2021, FONTE: QUALITY OF LIFE RESEARCH

INDEXADO EM:

WOS

TÃTULO: Changes in nerve conduction studies predate clinical symptoms onset in early onset Val30Met hereditary ATTR amyloidosis Full Text
AUTORES: Castro, J; Miranda, B; de Castro, I; Conceicao, I;
PUBLICAÇÃO: 2021, FONTE: EUROPEAN JOURNAL OF NEUROLOGY

INDEXADO EM:

Scopus

WOS

TÃTULO: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis Full Text
AUTORES: Alejandra Gonzalez Duarte; John L Berk; Dianna N Quan; Michelle L Mauermann; Hartmut H Schmidt; Michael Polydefkis; Marcia Waddington Cruz; Mitsuharu Ueda; Isabel M Conceicao; Arnt V Kristen; Teresa Coelho; Cecile A Cauquil; Celine Tard; Madeline Merkel; Emre Aldinc; Jihong H Chen; Marianne T Sweetser; Jing Jing Wang; David Adams;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF NEUROLOGY, VOLUME: 267, NÚMERO: 3

INDEXADO EM:

Scopus

WOS

TÃTULO: Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis Full Text
AUTORES: Teresa Coelho; Aaron Yarlas; Marcia Waddington Cruz; Michelle K White; Asia Sikora Kessler; Andrew Lovley; Michael Pollock; Spencer Guthrie; Elizabeth J Ackermann; Steven G Hughes; Chafic Karam; Sami Khella; Morie Gertz; Giampaolo Merlini; Laura Obici; Hartmut H Schmidt; Michael Polydefkis; James J B Dyck; Thomas H Brannagan; Isabel Conceicao; Merrill D Benson; John L Berk; ...Mais
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF NEUROLOGY, VOLUME: 267, NÚMERO: 4

INDEXADO EM:

Scopus

WOS

TÃTULO: A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis Full Text
AUTORES: Teresa Coelho; David Adams; Isabel Conceicao; Marcia Waddington Cruz; Hartmut H Schmidt; Juan Buades; Josep Campistol; John L Berk; Michael Polydefkis; Jing Jing Wang; Jihong H Chen; Marianne T Sweetser; Jared Gollob; Ole B Suhr;
PUBLICAÇÃO: 2020, FONTE: ORPHANET JOURNAL OF RARE DISEASES, VOLUME: 15, NÚMERO: 1

INDEXADO EM:

Scopus

WOS

TÃTULO: Toward an Understanding of the Factors Associated With Reproductive Concerns in Younger Female Cancer Patients. Evidence From the Literature
AUTORES: Ana Bártolo ; Isabel M Santos; Sara Monteiro ;
PUBLICAÇÃO: 2020, FONTE: Cancer Nursing, VOLUME: Publish Ahead of Print

INDEXADO EM:

CrossRef: 7

TÃTULO: Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
AUTORES: Arnt V Kristen; Senda Ajroud Driss; Isabel Conceicao; Peter Gorevic; Theodoros Kyriakides; Laura Obici;
PUBLICAÇÃO: 2019, FONTE: NEURODEGENERATIVE DISEASE MANAGEMENT, VOLUME: 9, NÚMERO: 1

INDEXADO EM:

Scopus

WOS

Página 2 de 8. Total de resultados: 80.

Links Úteis